Rodino-Klapac Louise bought SRPT
August 5, 2025 · Form 4 insider transaction
Rodino-Klapac Louise bought 6,250 shares of Sarepta Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
6,250
Price
$0.00
Total value
N/A
InsiderRodino-Klapac Louise
RoleOfficer
SecurityPerformance Stock Units
Transaction codeA: Grant or award
Transaction dateAugust 5, 2025
Filing dateAugust 6, 2025
Shares owned after6,250
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date.